10-Q · August 14, 2026
The filing does not disclose current-quarter revenue, margins, EPS, cash flow, balance-sheet figures, segment results, or quantitative guidance, so operating performance cannot be assessed from the provided text. The…
Earnings analysis · 10-Q
Filed September 21, 2026 · Our reading of the company's report
The latest report
Q2 2026 revenue increased to $524,927 from $407,644 in Q1, but diluted EPS deteriorated to negative $0.04 from negative $0.01. The more material development is the restatement of the June 30, 2026 financial statements,…
Q2 2026 revenue increased to $524,927 from $407,644 in Q1, but diluted EPS deteriorated to negative $0.04 from negative $0.01. The more material development is the restatement of the June 30, 2026 financial statements, including a $761,001 increase in assets and a corrected Tekne note fair value of $24,208,000. Ineffective disclosure controls, a prior fraudulent disbursement, and dependence on additional financing for remediation create significant execution and reporting risks.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Second-quarter revenue was $524,927, up from $407,644 in the first quarter of 2026, an increase of approximately 28.8%.
Reported diluted EPS was negative $0.04, compared with negative $0.01 in Q1 2026, indicating sequential earnings deterioration of $0.03 per share.
The restatement correction increased assets by $761,001 and raised the fair value of the Tekne convertible note receivable to $24,208,000.
Management identified a material weakness in controls over complex financial instrument accounting and presentation, as well as a separate weakness related to wire-transfer authorization.
The company intends to hire additional qualified personnel and adopt written accounting and financial-reporting policies during fiscal 2026 to remediate the identified weaknesses.
The company concluded that disclosure controls were not effective as of June 30, 2026, and stated that the weaknesses could result in financial-statement misstatements not being prevented or detected on a timely basis.
The control weakness resulted in restatement of the three- and six-month periods ended June 30, 2026; the correction increased assets by $761,001, highlighting exposure to complex-instrument valuation errors.
A wire-transfer authorization weakness resulted in a fraudulent disbursement during the fourth quarter of 2025, while remediation is partly dependent on obtaining additional financing.
The filing states that there were no material changes from the risk factors in the 2025 Form 10-K, so no new formal risk-factor additions were identified.
No quantitative revenue or EPS guidance is provided in the filing; the report states that there were no material changes to the risk factors from the 2025 Form 10-K.
The filing does not disclose current-quarter revenue, margins, EPS, cash flow, balance-sheet figures, segment results, or quantitative guidance, so operating performance cannot be assessed from the provided text. The…
BURU reported a revenue of $407,644 in Q1 2026, a notable return from zero in the same quarter a year prior, effectively marking a successful pivot in financial performance. The net loss for the quarter was reduced to…
BURU has pivoted its strategic focus towards a dual-use Defense & Security Platform, which has resulted in asset changes and an investment in software orchestration. However, the company is facing significant financial…
The company completed a strategic pivot from industrial lasers to a dual-use Defense & Security Platform (Transformation Plan adopted January 2025) while executing asset and portfolio changes (senior lenders completed a…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.